tirzepatide ndc number is approved by fda FDA says shortage of GLP-1 drug tirzepatide is over Zepbound 10 mg/0.5 mL injection

By mimicking natural hormones that control blood sugar and hunger, the Advanced GLP-1 Protocol helps reduce cravings, improve satiety, and promote sustainable weight management

Moreover, elevated insulin levels resulting from hyperinsulinemia trigger insulin-like growth factor (IGF) signaling, activating key pathways such as phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK) [26]

Meaningful body-composition change still takes consistent habits over months

An end-of-Phase 2 FDA meeting is planned for Q2 2026, with Phase 3 to start in the second half of the year